These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 6250729)
1. [Treatment of recurrent herpetic disease with specific inactive antigen]. Zábrodský S; Benda R Cesk Stomatol; 1980 Jul; 80(4):267-72. PubMed ID: 6250729 [No Abstract] [Full Text] [Related]
2. Natural cytotoxic cell activity linked to time of recurrence of herpes labialis. Rola-Pleszczynski M; Lieu H Clin Exp Immunol; 1984 Jan; 55(1):224-8. PubMed ID: 6319058 [TBL] [Abstract][Full Text] [Related]
3. Seventeen years of application of herpes vaccines in Bulgaria. Dundarov S; Andonov P Acta Virol; 1994 Aug; 38(4):205-8. PubMed ID: 7879710 [TBL] [Abstract][Full Text] [Related]
4. [Specific immunostimulation in the therapy of recurrent herpes simplex type I or II]. Veneroni G; Calixte C; Bozzo Costa E; Germogli R Boll Ist Sieroter Milan; 1987; 66(6):427-34. PubMed ID: 2839208 [TBL] [Abstract][Full Text] [Related]
5. [Recurrent herpes infections. Viral isolation and serological study]. Suárez M; Saavedra T; Phillips OM; Contreras Mdel C Med Cutan Ibero Lat Am; 1983; 11(1):55-60. PubMed ID: 6308366 [TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity to herpes simplex virus types 1 and 2 antigens in leukoplakia and carcinoma in man. Shillitoe EJ; Tarro G; Lehner T Oncology; 1976; 33(4):192-5. PubMed ID: 65753 [TBL] [Abstract][Full Text] [Related]
7. [The leukocyte migration inhibition test (LMIT) in recurrent herpes simplex labialis. Comparison of the results of treatment with BCG and Levamisole (author's transl)]. Jarisch R; Sandor I; Cerni C Arch Dermatol Res; 1979 May; 265(1):15-22. PubMed ID: 224827 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of patients with recurrent bullous herpes labialis with interferon ointment phonophoresis]. Durov VM; Kuznetsov VP; Antonova NI Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (2):58-9. PubMed ID: 6203221 [No Abstract] [Full Text] [Related]
9. A comparative study between viral isolation and indirect immunofluorescence in the diagnosis of herpes simplex virus. Galadari I; Fowzan AW Eur Ann Allergy Clin Immunol; 2006 Feb; 38(2):62-4. PubMed ID: 16711539 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in the understanding and treatment of herpes labialis (HSV-1). Blincoe GR; Miller RL J Ky Dent Assoc; 1979 Apr; 31(2):11-6. PubMed ID: 230265 [No Abstract] [Full Text] [Related]
11. Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis. Cunningham AL; Merigan TC J Immunol; 1984 Jan; 132(1):197-202. PubMed ID: 6418797 [TBL] [Abstract][Full Text] [Related]
12. Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis. Daniels CA; LeGoff SG Lancet; 1975 Sep; 2(7934):524-8. PubMed ID: 51344 [TBL] [Abstract][Full Text] [Related]
13. Letter: Possible prevention of bronchial carcinoma by recurrent Herpes simplex. Ross CA; Tyrrell WF Lancet; 1974 May; 1(7862):871. PubMed ID: 4132827 [No Abstract] [Full Text] [Related]
14. gamma Interferon production appears to predict time of recurrence of herpes labialis. Cunningham AL; Merigan TC J Immunol; 1983 May; 130(5):2397-400. PubMed ID: 6403619 [TBL] [Abstract][Full Text] [Related]